Pseudo-obstruction secondary to anticholinergic drugs in Parkinson's disease.
Howard
L M
LM
Markus
H
H
D006801:Humans; D007418:Intestinal Pseudo-Obstruction / Q000139:chemically induced*; D008127:Lofepramine / Q000009:adverse effects*; D008297:Male; D008333:Mandelic Acids / Q000009:adverse effects*; D008875:Middle Aged; D010276:Parasympatholytics / Q000009:adverse effects; D010300:Parkinson Disease / Q000188:drug therapy*
D008333:Mandelic Acids; D010276:Parasympatholytics; C005419:oxybutynin; D008127:Lofepramine